FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely endocrinology and gynecology, and discloses method for diagnosing anovulation. Method consists in determining the level of testosterone and melatonin in blood and when testosterone is more than 2.1 nmol/l and melatonin is more than 12 pg/ml, anovulation is diagnosed. Method improves accuracy of identification of folliculogenesis disorders and does not require long-term ultrasound monitoring, has no connection with the cycle day and can be used to diagnose anovulation and, as a consequence, infertility in women.
EFFECT: method allows to standardize and simplify diagnosis of anovulation, to reveal predictors of abnormalities in reproductive system.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSTICS OF MENSTRUAL DYSFUNCTION AGAINST BACKGROUND OF POLYCYSTIC OVARIAN SYNDROME BY IMMATURE GIRLS | 2013 |
|
RU2535096C1 |
METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
METHOD FOR PREDICTION OF MENSTRUAL RECOVERY IN ADOLESCENT GIRLS WITH NORMOGONADOTROPIC OLIGOMENORRHEA | 2020 |
|
RU2740848C1 |
METHOD OF DIAGNOSTICS OF AGE ANDROGENIC DEFICIENCY IN WOMEN | 2022 |
|
RU2802126C1 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF METFORMIN AND/OR WEIGHT-LOSS THERAPY IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME | 2010 |
|
RU2427842C1 |
DIAGNOSTIC TECHNIQUE FOR HYPERANDROGENISM SYNDROME IN WOMEN OF REPRODUCTIVE AGE | 2010 |
|
RU2461354C2 |
METHOD OF DERMATOSIS DEVELOPMENT PREDICTION IN WOMEN WITH SCLEROPOLYCYSTIC OVARIAN SYNDROME (SPCO) | 2008 |
|
RU2367954C1 |
METHOD FOR ESTIMATING DEGREE OF SEVERITY OF OVARIAN DYSFUNCTION IN GIRLS WITH PUBERAL HYPERANDROGENISM | 2018 |
|
RU2690502C1 |
METHOD FOR AROMATASE ACTIVITY TEST | 2012 |
|
RU2481587C1 |
METHOD FOR PREDICTING THE RISK OF REPRODUCTIVE DISORDERS IN WOMEN WITH SUBCLINICAL AND OVERT HYPOTHYROIDISM | 2022 |
|
RU2804212C1 |
Authors
Dates
2018-04-16—Published
2016-12-27—Filed